ResearchPUBMED3 days ago
Researchers in Germany studied health insurance records from 2017-2019 to understand how hemophilia A (a bleeding disorder) affects patients and how much it costs to treat. They found 257 patients with hemophilia A and grouped them by severity—mild, moderate, or severe—based on how much clotting medicine they needed. This study shows that insurance data can help doctors and researchers learn more about rare diseases like hemophilia A.
WHY IT MATTERSIf you have hemophilia A in Germany, this research demonstrates that your health insurance claims data can be used to better understand disease patterns, treatment costs, and care gaps—potentially leading to improved healthcare planning and resource allocation for your condition.
ResearchPUBMEDApr 9
Researchers studied how digital tools like telemedicine and online apps can help patients with phenylketonuria (PKU), a rare genetic disorder affecting how the body processes certain proteins. They surveyed PKU patients and doctors in Spain, Germany, and Ireland to understand what digital tools work best for managing this condition that requires regular check-ups and careful monitoring. The study shows that digital health tools became more important during COVID-19 and can help patients stay connected with their doctors and learn more about their condition.
WHY IT MATTERSIf you have PKU or care for someone with PKU, this research identifies which digital tools patients actually want and need to manage their condition better and communicate with their healthcare team.
ResearchPUBMEDMar 26
This study looked at how long it takes to diagnose APDS, a very rare immune system disorder that affects only 1-2 people per million. Researchers interviewed patients and doctors in Austria, Germany, and Switzerland and found that people typically wait several years before getting a correct diagnosis because the disease is so uncommon and looks different in different people.
WHY IT MATTERSPatients with APDS face years of diagnostic delay due to the disease's rarity and variable symptoms — understanding these barriers could help doctors recognize APDS faster and reduce the time families spend seeking answers.